Recent posts
- 5/8 Ambrisentan Fails in Lung Fibrosis >
- 4/18 Genome-Wide Association Study Identifies Multiple Susceptibility Loci for Pulmonary Fibrosis >
- 4/18 Genetic Variants Associated with Idiopathic Pulmonary Fibrosis Susceptibility and Mortality: A Genome-Wide Association Study >
- 4/16 Pulmonary Fibrosis Patients, Advocacy Groups Applaud FDA Decision to Add Untreatable Lung Disease as Part of Five-Year Patient-Focused Drug Development Program >
- 4/11 Prescription Drug User Fee Act Patient-Focused Drug Development; Announcement of Disease Areas for Meetings Conducted in Fiscal Years 2013–2015 >
- 3/28 UW Medicine Establishes Center for Interstitial Lung Diseases >
- 3/27 Pulmonary Fibrosis Foundation Announces Open Registration for International Health Care Conference on Pulmonary Fibrosis >
- 3/26 NICE Recommends Drug for Idiopathic Pulmonary Fibrosis in Latest Draft Guidance >
Archive
- May 2013 (1)
- April 2013 (5)
- March 2013 (5)
- February 2013 (3)
- January 2013 (4)
- December 2012 (1)
- November 2012 (2)
- October 2012 (4)
- September 2012 (5)
- August 2012 (2)
Sort by Category
- Medical News (61)
- News Story (31)
- Patient Stories (15)
- Advocacy (14)
- PFF in the News (13)
- PFF News (9)
- Interviews (8)
- Breakthroughs (7)
- Interventional (6)
